US Warrant News

Immune Pharmaceuticals Inc. Announces Closing Of Public Offering Of Common … – MarketWatch

Immune Pharmaceuticals Inc. Announces Closing Of Public Offering Of Common …MarketWatchSeparately, $1.0 million recently invested in the Company privately by an existing investor converted into 400,000 units, consisting of 400,000 shares of common stock and warrants to purchase up to 100,000 shares of common stock at the same term as the … and more …read […]

Immune Pharmaceuticals Inc. Announces Closing Of Public Offering Of Common … – MarketWatch Read More »

Eleven Biotherapeutics Announces Additional Financing of $20 Million – FierceBiotech

Eleven Biotherapeutics Announces Additional Financing of $20 MillionFierceBiotechThe investment in Eleven consists of the sale and issuance of 1,743,680 shares of common stock at $11.47 per share, the closing bid price reported by NASDAQ on November 24, 2014, as well as the sale and issuance of warrants to purchase approximately … and more …read more

Eleven Biotherapeutics Announces Additional Financing of $20 Million – FierceBiotech Read More »

Eleven Biotherap (EBIO) Reports $20M Securities Purchase Agreement – StreetInsider.com (subscription)

Eleven Biotherap (EBIO) Reports $20M Securities Purchase AgreementStreetInsider.com (subscription)The investment in Eleven consists of the sale and issuance of 1,743,680 shares of common stock at $11.47 per share, the closing bid price reported by NASDAQ on November 24, 2014, as well as the sale and issuance of warrants to purchase approximately … …read more

Eleven Biotherap (EBIO) Reports $20M Securities Purchase Agreement – StreetInsider.com (subscription) Read More »

Eleven Biotherapeutics Announces Additional Financing of $20 Million – MarketWatch

Eleven Biotherapeutics Announces Additional Financing of $20 MillionMarketWatchThe investment in Eleven consists of the sale and issuance of 1,743,680 shares of common stock at $11.47 per share, the closing bid price reported by NASDAQ on November 24, 2014, as well as the sale and issuance of warrants to purchase approximately … and more …read more

Eleven Biotherapeutics Announces Additional Financing of $20 Million – MarketWatch Read More »

NXP Semiconductors N.V. Announces Pricing of Private Offering of $1 Billion of … – Nasdaq

NXP Semiconductors N.V. Announces Pricing of Private Offering of $1 Billion of …NasdaqThe warrant transactions will be net share settled upon exercise and could therefore have a dilutive effect with respect to NXP’s common stock to the extent that the market price per share of NXP’s common stock exceeds the strike price of the warrants.

NXP Semiconductors N.V. Announces Pricing of Private Offering of $1 Billion of … – Nasdaq Read More »

NXP Semiconductors N.V. Announces Pricing of Private Offering of $1 Billion of … – CNNMoney

NXP Semiconductors N.V. Announces Pricing of Private Offering of $1 Billion of …CNNMoneyThe warrant transactions will be net share settled upon exercise and could therefore have a dilutive effect with respect to NXP’s common stock to the extent that the market price per share of NXP’s common stock exceeds the strike price of the warrants.

NXP Semiconductors N.V. Announces Pricing of Private Offering of $1 Billion of … – CNNMoney Read More »

Workday’s (WDAY) CEO Aneel Bhusri on Q3 2015 Results – Earnings Call … – Seeking Alpha

Seeking AlphaThe share count includes 6.9 million weighted average shares from our January follow-on offerings. Given our net loss, all outstanding stock options, warrants and common stock equivalents are anti-dilutive and not included in the loss per share …Workday Announces Fiscal 2015 Third Quarter Financial ResultsMarketWatch all 34 news articles …read more

Workday’s (WDAY) CEO Aneel Bhusri on Q3 2015 Results – Earnings Call … – Seeking Alpha Read More »

Scroll to Top